Has Novo Nordisk received European approval for its Wegovy weight loss pill?

Yes. The European Commission has granted marketing authorization for Novo Nordisk’s Wegovy pill for people with obesity or those who are overweight. This approval gives Novo a head start over Eli Lilly’s still‑pending oral GLP‑1 candidate, Foundayo, positioning the company to strengthen its obesity market presence in Europe.